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ABSTRACT 
Sudden cardiac death (SCD) is an unexpected death condition and occurs with unknown 
causes or cardiac condition. The SCD incidence at young age is a rare condition but when this 
condition happens it become traumatic event for both family and community.  Incidence rate of 
death on 1-35 years old is around 0.8-2.8/100.000 each year. This number also varies 
according to age and sex. Death incidence on 1-4 years old is more common than on 5-10 
years old group. This number is increasing after 15 years old, where age of 31-35 years has 10 
fold risk of SCD compared to 1-10 years old group. Ratio of SCD in men and woman are 2: 1. 
Early detection of underlying heart disease is the most important action of preventio. If young 
people are known to have a risk of SCD, the lifestyle changing and appropriate medical therapy, 
including implantation of implantable cardioverter defibrillator, according to risk stratification 
must be done. 
 
Etiology 
The underlying mechanism of 
sudden cardiac death (SCD) with normal 
heart is still not fully understood. In 50% of 
cases with a normal heart structure, SCD is 
the first manifestation of an illness.1 The 
combination of precipitating factors and 
susceptible myocardium may be the initial 
factors that underlie lethal arrhythmias that 
cause in SCD.1  
Cardiac abnormalities that underlie 
SCD at a young age individual including 
congenital heart disease, coronary artery 
abnormalities, myocarditis, hypertrophic 
cardiomyopathy, dilated cardiomyopathy, 
left ventricular non-compaction cardio-
myopathy, arrhythmogenic right ventricular 
cardiomyopathy (ARVC) and  electrical 
channel disturbances (channelopathies) 
such as long QT syndrome (LQTS), 
catecholaminergic polymorphic ventricular 
tachycardia (CPVT) and Brugada 
syndrome.2,3,4  
Coronary heart disease is still the 
main cause cardiac abnormality in the older 
age group, while abnormalities of electrical 
channel cardiomyopathy or channelopathies 
are more common at a young age 
individual. An autopsy is not always 
performed in individual who experiences 
SCD, so there is often bias in identifyng 
incidents and determining the cause of 
death. Several methods have been 
investigated to reduce and prevent SCD in 
population, one of which is by 
electrocardiograms (ECG) screening in 
certain populations such as in athletes.5  
 




Prodormal Symptom and Warning 
Sign 
Identification of prodormal symptom 
and clinical signs in SCD group is very 
important. Predictive ability can be used as 
a reference in conducting interventions such 
as diagnostic screening, primary prevention 
or implantation of ICD. Symptoms which 
arise will be associated with underlying 
heart disease condition.6 Symptoms such 
as chest pain, palpitations and shortness of 
breath are not specific. Syncope and 
presyncope become one of the most 
frequent symptoms that precede cardiac 
arrest incidence.5 Other prodormal 
symptoms are that associated with sudden 
cardiac arrest are non-sustained 
arrhythmias that accompanied by 
palpitations, chest pain, syncope and 
seizures. This condition demonstrates 
fluctuations of blood pressure and pulse 
pressure. Risk of SCD will increase if those 
symptoms appear accompanied by cardiac 
abnormalities.6  
An aggressive diagnosis is needed 
to determine heart abnormalities before 
SCD occurs. An SCD becomes high risk 
marker of future cardiac arrest. Symptoms 
such as chest pain, palpitations, shortness 
of breath, presyncope and syncope are not 
typical but these complaints can be used as 
a warning sign of a dangerous heart 
abnormality.5 Evaluation of overall heart 
condition needs to be done immediately in 
young populations who experience chest 
pain during exercise that is not affected by 
movement, inspiration, or palpation and 
without a clear non-cardiac cause, 
especially in patients at high risk of cardiac 
abnormalities, a history of sudden death in 
the family, or syncope during training that is 




An SCD often becomes first 
symptom that occurs and underlies heart 
abnormalities at a young age, therefore 
clear concept of cardiovascular screening is 
needed. Screening can recognize or 
increase suspicion of cardiac abnormalities 
in people that previously not been known of 
cardiac abnormalities. It can reduce the 
incidence of SCD in asymptomatic 
individual. Screening will give a time to SCD 
prevention interventions in risk group 
population. Prevention actions that can be 
performed include avoiding excessive 
physical activity or competitive sports, 
appropriate medication according to heart 
disorders (e.g. beta blockers in LQTS and 
CPVT) and primary prevention with ICD 
placement in high-risk individual. Screening 
programs can also be targeted at certain 
populations or subgroups, for example in 
athletes. However, SCD can appear at rest 
or during mild activity.5  
History of disease and physical 
examination are less effective in identifying 
risk groups. Therefore, use of standard 12 
leads electrocardiography (ECG) can 
provide additional screening data to detect 
underlying heart abnormalities. Resting 
electrocardiography can assess several 
etiologies of sudden cardiac death such as 
HCM, LQTS, Brugada syndrome, ARVC 
and Wolf Parkinson's white syndrome. 
However the positive predictive value (PPV) 
of ECG in assessing cardiac pathology is 
quite low. Therefore a number of other 
effective screening modalities are needed 
so that they can get rid of cardiovascular 
abnormalities. For example, T wave 
inversion in the right precordial leads of 
ECG is a typical picture for ARVC, but this 
picture can be normal in the general 




population and not related to cardiac 
structural abnormalities.5  
Some working groups recommend a 
history of cardiac history and physical 
examination must to be standard in 
screening the risk of SCD (especially on 
athletes). Several studies shown history and 
physical examination are become screening 
tools that have clinical value that 
accompanied by additional test such as 
echocardiography, ECG and genetic 
examination.8  
 
Risk Stratification and Prevention 
Substrate Identification of cardiac 
abnormalities is a key in prevention of SCD. 
However, only a few SCD at a young age 
was found to have been known to have had 
a previous heart disorder. If the diagnosis is 
made with a high risk, specific prevention 
including ICD monitoring can be done. The 
use of ICD implantation for primary 
prevention at a young age is increasing in 
number. Cardiac electrical abnormalities, 
cardiomyopathy and congenital heart 
abnormalities are the most common causes 
of ICD implantation at a young age as 
primary prevention purpose. Primary 
prevention is also aimed at young 
populations with a decrease in heart 
function (ejection fraction) of less than 30-
35%. As for secondary prevention, ICD 
insertion is intended for patients with a 
history of cardiac arrest, ventricular 
tachycardia with unstable reversible 
hemodinamic causes has been excluded. 
Some conditions such as HCM, ARVC, 
LQTS, CPVT and Brugada syndrome, 
prevention can be done with lifestyle 
modification, medication, device use can be 
suggested to children and young people.5 
Patients who identified a high risk 
group for cardiac arrest, ICD implantion 
should be considered as primary 
prevention. An ICD implantation in adults 
has been shown to provide benefits in 
patients with ischemic cardiomyopathy and 
left ventricular dysfunction. While for 
children, the benefits of ICD implantation 
are still unclear. Implanted ICD in children 
sometimes provides complications related 
to fitting with the devices, contain 
inappropriate shock, malfunction leads and 
technical difficulties in ICD implantation. On 
the other hand, ICD implantation is still 
needed as a primary prevention specifically 
for the incidence of cardiac arrest due to 
cardiac abnormalities and arrhythmias due 
to cardiomyopathy.6  
 
Conclusion 
Sudden cardiac death rarely occurs 
at a young age. In some conditions this can 
be prevented by screening on high risk 
populations. The prodromal symptoms, 
history of SCD in family at a young age, or 
high risk behavior can increase alertness for 
the possibility of SCD. Family risk must be 
searched especially in cases that clearly 
caused by genetic mutations, such that the 
risk stratification must be performed. 
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